Antitumor Activity of a Novel Oral STAT3 Inhibitor YHO‐1701

Cancer Science - United States
doi 10.1111/cas.14369
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Characterization of a Novel PERK Kinase Inhibitor With Antitumor and Antiangiogenic Activity

Cancer Research
Cancer ResearchOncology
2013English

Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor

International Journal of Oncology
Cancer ResearchOncology
2014English

SKLB-287, a Novel Oral Multikinase Inhibitor of EGFR and VEGFR2, Exhibits Potent Antitumor Activity in LoVo Colorectal Tumor Model

Neoplasma
Cancer Research
2014English

Identification and Antitumor Activity of a Novel Inhibitor of the NIMA-related Kinase NEK6

Scientific Reports
Multidisciplinary
2018English

Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- And Radio-Sensitivity in Nasopharyngeal Carcinoma

PLoS ONE
Multidisciplinary
2013English

Identification of a Novel Potential Antitumor Activity of Gossypol as an APE1/Ref-1 Inhibitor

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Targeting Constitutively-Activated STAT3 in Hypoxic Ovarian Cancer, Using a Novel STAT3 Inhibitor

Oncoscience
Cancer ResearchOncology
2014English

Biphenyl-4-Yl-Acrylohydroxamic Acids: Identification of a Novel Indolyl-Substituted HDAC Inhibitor With Antitumor Activity

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2016English

Antitumor Activity of Novel Pyrazole-Based Small Molecular Inhibitors of the STAT3 Pathway in Patient Derived High Grade Glioma Cells

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy